Photo of Luke Peppone taken from www.urmc.rochester.edu
Mar 28, 2024, 14:32
Luke Joseph Peppone: High-dose vitamin D significantly reduced bone loss in patients with prostate cancer
Luke Joseph Peppone, Associate Professor – Department of Surgery, Cancer Control (SMD), shared the following post on by ACS Journal Cancer on X, adding the following:
“New Publication
High-dose vitamin D significantly reduced bone loss in patients with prostate cancer in our latest clinical trial! A huge team effort by Supriya Mohile, Chunkit Fung, Amber Kleckner, Michelle Janelsins, Jonathan Friedbergand a special thank you to the participants!”
Quoting ACS Journal Cancer’s post:
“New from Luke Joseph Peppone et al | High-dose vitamin D to attenuate bone loss in patients with prostate cancer on androgen deprivation therapy: A phase 2 RCT.”
Source: Luke Joseph Peppone/X and ACS Journal Cancer/X
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 20, 2025, 17:47
Mar 20, 2025, 17:37
Mar 20, 2025, 17:29
Mar 20, 2025, 16:59
Mar 20, 2025, 15:17